Complement Regulatory Proteins Expression and Clinical Response in Rheumatoid Arthritis (RA) Patients Treated With Rituximab
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01096069|
Recruitment Status : Unknown
Verified March 2010 by Hospital de Clinicas de Porto Alegre.
Recruitment status was: Not yet recruiting
First Posted : March 30, 2010
Last Update Posted : March 30, 2010
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||10 participants|
|Official Title:||Expressão de Cregs e a Resposta clínica em Pacientes AR Tratada Com Rituximabe|
|Study Start Date :||June 2010|
|Estimated Primary Completion Date :||December 2010|
|Estimated Study Completion Date :||December 2011|
Rheumatoid arthritis patients undergoing treatment with rituximab.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01096069
|Contact: Ricardo M Xavier, PhDemail@example.com|
|Contact: Ana P Alegretti, Masterfirstname.lastname@example.org|
|Study Director:||Ricardo M Xavier, PhD||HCPA|